Metabolic Activation and Covalent Protein Binding of Berberrubine: Insight into the Underlying Mechanism Related to Its Hepatotoxicity

References

• DunnickJK, SinghB, NyskaA, et al. Investigating the potential for toxicity from long-term use of the herbal products, goldenseal and milk thistle. Toxicol Pathol. 2011;39(2):398–409. doi:10.1177/019262331039421121300790
   PubMed Web of Science ®Google Scholar
• BloweyDL. Nephrotoxicity of over-the-counter analgesics, natural medicines, and illicit drugs. Adolesc Med Clin. 2005;16(1):31–43. doi:10.1016/j.admecli.2004.10.00115844382
   PubMedGoogle Scholar
• PerazellaMA. Pharmacology behind common drug nephrotoxicities. Clin J Am Soc Nephrol. 2018;13:1897–1908.29622670
   PubMed Web of Science ®Google Scholar
• RandyL, MarkA. Aristolochic acid nephropathy: epidemiology, clinical presentation and treatment. Drug Saf. 2015;38(1):55–64. doi:10.1007/s40264-014-0244-x25446374
   PubMed Web of Science ®Google Scholar
• DebelleDF, VanherweghemJL, NortierJL. Aristolochic acid nephropathy: A worldwide problem. Kidney Int. 2008;74(2):158–169. doi:10.1038/ki.2008.12918418355
   PubMed Web of Science ®Google Scholar
• JadotI, DeclèvesAE, NortierJ, et al. An integrated view of aristolochic acid nephropathy: update of the literature. Int J Mol Sci. 2017;18(2):297. doi:10.3390/ijms18020297
   PubMed Web of Science ®Google Scholar
• BastekH, ZubelZ, StemmeK, et al. Comparison of aristolochic acid I derived DNA adduct levels in human renal toxicity models. Toxicology. 2019;420:29–38. doi:10.1016/j.tox.2019.03.01330940547
   PubMed Web of Science ®Google Scholar
• PriestapHA, SantosCD, QuirkJM. Identification of a reduction product of aristolochic acid: implications for the metabolic activation of carcinogenic aristolochic acid. J Nat Prod. 2010;73(12):1979–1986. doi:10.1021/np100296y21141875
   PubMed Web of Science ®Google Scholar
• LiWW, LinDG, GaoHY, et al. Metabolic activation of furan moiety makes Diosbulbin B hepatotoxic. Arch Toxicol. 2016;90(4):863–872. doi:10.1007/s00204-015-1495-825851819
   PubMed Web of Science ®Google Scholar
• WangJM, JiLL, LiuH, et al. Study of the hepatotoxicity induced by Dioscoreabulbifera L. rhizome in mice. Biosci Trends. 2010;4:79–85.20448345
   PubMed Web of Science ®Google Scholar
• LinDG, LiCY, PengY, et al. Cytochrome P450–mediated metabolic activation of Diosbulbin B. Drug Metab Dispos. 2014;42(10):1727–1736. doi:10.1124/dmd.114.05926125024403
   PubMed Web of Science ®Google Scholar
• LinDJ, LiWW, PengY, et al. Role of metabolic activation in 8-Epidiosbulbin E acetate-induced liver injury: mechanism of action of the hepatotoxic furanoid. Chem Res Toxicol. 2016;29(3):359–366. doi:10.1021/acs.chemrestox.5b0050126886724
   PubMed Web of Science ®Google Scholar
• WangK, LinDG, GuoXC, et al. Chemical identity of interaction of protein with reactive metabolite of Diosbulbin B in vitro and in vivo. Toxins. 2017;14(8):249.
   Web of Science ®Google Scholar
• ZhouSF, XueCC, WangGG, WangG. Metabolic activation of herbal and dietary constituents and its clinical and toxicological implications: an update. Curr Drug Metab. 2007;8(6):526–553. doi:10.2174/13892000778136886317691916
   PubMed Web of Science ®Google Scholar
• TripathiAN, ChauhanL, ThankachaPP, et al. Quantum chemical and nuclear magnetic resonance spectral studies on molecular properties and electronic structure of berberine and berberrubine. Magn. Reson. Chem. 2007;45(8):647–655. doi:10.1002/mrc.201917559166
   PubMed Web of Science ®Google Scholar
• WangK, FengXC, ChaiLW, et al. The metabolism of berberine and its contribution to the pharmacological effects. Drug Metab Rev. 2017;49(2):139–157. doi:10.1080/03602532.2017.130654428290706
   PubMed Web of Science ®Google Scholar
• ChenML, XianYF, LpSU, et al. Chemical and biological differentiation of Cortex Phellodendri Chinensis and Cortex Phellodendri Amurensis. Planta Med. 2010;76(14):1530–1535. doi:10.1055/s-0030-124977420354951
   PubMed Web of Science ®Google Scholar
• GilcaM, GamanL, PanaitE, et al. Chelidonium majus-an integrative review: traditional knowledge versus mod-ern findings. Forsch Komplementmed. 2010;17(5):241–248. doi:10.1159/00032139720980763
   PubMedGoogle Scholar
• ZhouY, CaoSJ, WangY, et al. Berberine metabolites could induce low density lipoprotein receptor up-regulation to exert lipid-lowering effects in human hepatoma cells. Fitoterapia. 2014;92:230–237. doi:10.1016/j.fitote.2013.11.01024321576
   PubMed Web of Science ®Google Scholar
• HuJP, TakahashiNT, YamadaT. Coptidis rhizoma inhibits growth and pro-teases of oralbacteria. Oral Dis. 2000;6(5):297–302. doi:10.1111/j.1601-0825.2000.tb00142.x11002412
   PubMed Web of Science ®Google Scholar
• WrightCW, MarshallSJ, RussellPF, et al. In vitro antiplasmodial, antiamoebic, and cytotoxic activities of some monomeric isoquinoline alkaloids. J Nat Prod. 2000;63(12):1638–1640. doi:10.1021/np000144r11141105
   PubMed Web of Science ®Google Scholar
• BairdAW, TaylorCT, BraydenDJ. Non-antibiotic anti-diarrhoeal drugs: factors affecting oral bioavailability of berberine and loperamide in intestinal Tissue.Adv. Drug Deliv Rev. 1997;23(1–3):111–120. doi:10.1016/S0169-409X(96)00429-2
   Web of Science ®Google Scholar
• ChenGR, XuYB, JingJ, et al. The anti-sepsis activity of the components of Huanglian Jiedu Decoction with high lipid A-binding affinity[J]. Int Immunopharmacol. 2017;46:87–96. doi:10.1016/j.intimp.2017.02.02528278436
   PubMed Web of Science ®Google Scholar
• MaHL, LiuY, MaiX, et al. Identification of the constituents and metabolites in rat plasma after oral administration of HuanglianShangqing pills by ultra high-performance liquid chromatography/quadrupole time-of-flight mass spectrometry[J]. J Pharm Biomed Anal. 2016;125:194–204. doi:10.1016/j.jpba.2016.03.03827031575
   PubMed Web of Science ®Google Scholar
• HuangWY, DongH. Coptidis Rhizoma-Contained Traditional Formulae for Insomnia: A Potential to Prevent Diabetes?[J]. Chin J Integr Med. 2018;24(10):785–788. doi:10.1007/s11655-018-3012-430267370
   PubMed Web of Science ®Google Scholar
• YangN, SunRB, ZhaoYQ, et al. High fat diet aggravates the nephrotoxicity of berberrubine byinfluencingon its pharmacokinetic profile. Environ Toxicol Pharmacol. 2016;46:319–327. doi:10.1016/j.etap.2016.08.00327525563
   PubMed Web of Science ®Google Scholar
• JinX, YanTH, YanY, et al. Design, synthesis, and anticancer activity of novel berberine derivatives prepared via CuaaC “click” chemistry as potential anticancer agents. Drug Des Devel Ther. 2014;8:1047–1059. doi:10.2147/DDDT.S63228
   PubMed Web of Science ®Google Scholar
• WangK, LiWW, ChenJM, et al. Detection of cysteine- and lysine-based protein adductions by reactive metabolites of 2,5-dimethylfuran. Anal Chim Acta. 2015;896:93–101. doi:10.1016/j.aca.2015.09.01726481992
   PubMed Web of Science ®Google Scholar
• WangXQ, WangSH, MaJS, et al. Pharmacokinetics in rats and tissue distribution in mouse of berberrubine by UPLC-MS/MS. J Pharm Biomed Anal. 2015;115:368–374. doi:10.1016/j.jpba.2015.07.03126279368
   PubMed Web of Science ®Google Scholar
• WangK, ChaiLW, FengXC, et al. Metabolites identification of berberine in rats using ultra-high performance liquid chromatography/quadrupole time-of-flight mass spectrometry[J]. J Pharm Biomed Anal. 2017;139:73–86. doi:10.1016/j.jpba.2017.02.03828279930
   PubMed Web of Science ®Google Scholar
• TanXS, MaJY, FengR, et al. Tissue Distribution of Berberine and Its Metabolites after Oral Administration in Rats[J]. PLoS One. 2013;8.
   Web of Science ®Google Scholar
• SinghN, SharmaB. Toxicological Effects of Berberine and Sanguinarine[J]. Front Mol Biosci. 2018;19:5–21.
   Google Scholar
• KępkaA, ZwierzP, ChojnowskaS, et al. Relation of plasma carnitine and aminotransferases to alcohol dose and time of dependence[J]. Alcohol. 2019;81:62–69. doi:10.1016/j.alcohol.2019.04.00431029632
   PubMed Web of Science ®Google Scholar
• PolS, NalpasB, VassaultA, et al. Hepatic activity and mRNA expression of aspartate aminotransferase isoenzymes in alcoholic and nonalcoholic liver disease[J]. Hepatology. 1991;14:620–625.1916663
   PubMed Web of Science ®Google Scholar
• McGillMR, JaeschkeJ. Animal models of drug-induced liver injury[J]. Biochim Biophys Acta Mol Basis Dis. 2019;1865(5):1031–1039. doi:10.1016/j.bbadis.2018.08.03731007174
   PubMed Web of Science ®Google Scholar
• JaeschkeH, WilliamsCD, RamachandranA, et al. Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity[J]. Liver Int. 2012;32(1):8–20. doi:10.1111/j.1478-3231.2011.02501.x21745276
   PubMed Web of Science ®Google Scholar
• KaplowitzN. Idiosyncratic drug hepatotoxicity. Nat Rev Drug Discov. 2005;4(6):489–499. doi:10.1038/nrd175015931258
   PubMed Web of Science ®Google Scholar
• YaseminHB, CeylanAK, UfukKC. Liver immunology and herbal treatment. World J Hepatol. 2017;9(17):757–770. doi:10.4254/wjh.v9.i17.75728660010
   PubMed Web of Science ®Google Scholar
• GaoB, JeongWI, TianZG. Liver: an organ with predominant innate immunity. Hepatology. 2008;47(2):729–736. doi:10.1002/hep.2203418167066
   PubMed Web of Science ®Google Scholar
• GunawanB, KaplowitzN. Clinical perspectives on xenobiotic-induced hepatotoxicity. Drug Metab Rev. 2004;36(2):301–312. doi:10.1081/DMR-12003414815237856
   PubMed Web of Science ®Google Scholar
• WangK, WangH, PengY, et al. Identification of Epoxide-Derived Metabolite(s) of Benzbromarone[J]. Drug Metab Dispos. 2016;44(4):607–615. doi:10.1124/dmd.115.06680326792818
   PubMed Web of Science ®Google Scholar
• WangK, LinDJ, GuoXC, et al. Chemical Identity of Interaction of Protein with Reactive Metabolite of Diosbulbin B In Vitro and In Vivo[J]. Toxins. 2017;9(8):249–264. doi:10.3390/toxins9080249
   PubMed Web of Science ®Google Scholar
• LanJR, ZhaoYY, DongFX, et al. Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. J Ethnopharmacol. 2015;161:69–81.25498346
   PubMed Web of Science ®Google Scholar
• AhmedT, GilaniAH, AbdollahiM, et al. Berberine and neurodegeneration: a review of literature. Pharmacol Rep. 2015;67(5):970–979. doi:10.1016/j.pharep.2015.03.00226398393
   PubMed Web of Science ®Google Scholar
• KaboliPJ, RahmatA, IsmailP, et al. Targets and mechanisms of berberine, a natural drug with potential to treat cancer with special focus on breast cancer. Eur J Pharmacol. 2014;740:584–595. doi:10.1016/j.ejphar.2014.06.02524973693
   PubMed Web of Science ®Google Scholar